Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm





    Chief Complaint


    Organ System


    Patent Pending

    Framingham Coronary Heart Disease Risk Score

    Estimates risk of heart attack in 10 years.


    There are several distinct Framingham risk models. MDCalc uses the 'Hard' Coronary Framingham outcomes model, which is intended for use in non-diabetic patients age 30-74 years with no prior history of coronary heart disease or intermittent claudication, as it is the most widely applicable to patients without previous cardiac events. See the official Framingham website for additional Framingham risk models.
    When to Use
    Use in patients aged 30-74 years with no prior history of coronary heart disease. Do not use in patients with intermittent claudication or diabetes.
    The Framingham data, while thorough, come from many years ago with a potentially different US population along with a different diet and level of smoking as well, which may suggest different risk levels today.
    mm Hg


    Please fill out required fields.

    Next Steps
    Creator Insights


    Patients with high risk scores should be counseled aggressively about social factors contributing to their risk (smoking, exercise, weight, diet, etc) and also managed with blood pressure and lipid evaluation.


    Addition of points assigned to ranges of values in risk factors. See links below.

    Facts & Figures

    Score sheets:

    For other Framingham Risk Calculators, visit the Official Framingham Website.

    Dr. Peter W.F. Wilson

    About the Creator

    Peter W. F. Wilson, MD, is professor of medicine in the cardiology division of Emory University and a professor of public health at the Rollins School of Public Health. He is currently the director of epidemiology and genomic medicine at the Atlanta VA Medical Center. Dr. Wilson researches metabolic and cardiovascular population issues, focusing on determinants of CAD, including diabetes mellitus, hormonal factors, inflammatory markers, and genetics.

    To view Dr. Peter W.F. Wilson's publications, visit PubMed